Competitive intelligence on 
 small-molecule drugs and 
 the 90,000 global patents 
 covering them 

Start your free trial now

DrugPatentWatch Ultimate Plan Preview

Details for Patent: 5,378,804

« Back to Dashboard

Patent 5,378,804 protects CANCIDAS and is included in one NDA. There has been one Paragraph IV challenge on Cancidas. There is one tentative approval for the compound protected by this patent. Additional details are available via the generic ingredient links below.

Protection for CANCIDAS has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

Summary for Patent: 5,378,804

Title: Aza cyclohexapeptide compounds
Abstract:Aza cyclohexapeptide compounds are disclosed with a nitrogen attached to the cyclohexapeptide ring at the 5-carbon of the 4-hydroxyornithine component. Such compounds are represented by the formula: ##STR1## The compounds are disclosed as having antifungal, antiprotozoal and anti-Pneumocystis carinii activity.
Inventor(s): Balkovec; James M. (North Plainfield, NJ), Black; Regina M. (Cranford, NJ), Bouffard; Frances A. (Scotch Plains, NJ)
Assignee: Merck & Co., Inc. (Rahway, NJ)
Application Number:08/032,847
Patent Claim Types:
see list of patent claims
Compound;
Patent PDF download available with subscription

Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Merck
CANCIDAS
caspofungin acetate
INJECTABLE;IV (INFUSION)021227Jan 26, 2001RXYes5,378,804*PED<disabled>
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Patent: 5,378,804

Country Document Number Publication Date
South Africa9401807Oct 13, 1994
World Intellectual Property Organization (WIPO)9421677Sep 29, 1994
United States of America5514650May 07, 1996
United States of America5792746Aug 11, 1998
Slovakia113695Feb 07, 1996
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000   2001   2002   2003   2004   2005   2006   2007   2008   2009   2010   2011   2012   2013  

For more information try a free trial or see the plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: PatentStatBiotechBlogJournal of Commercial Biotechnology

`abc